Expression and function of activin beta A during mouse cardiac cushion tissue formation.
The formation of cardiac cushion tissue, which ultimately contributes to formation of the valves and septa, is dependent on the regional activation of cardiac endothelial cells to undergo an epithelial-mesenchymal transition. This endothelial transition was correlated with activin betaA mRNA expression by Northern and in situ hybridization in both a temporal and spatial manner in developing mouse embryos. Activin betaA was the only subunit of the inhibin family detected during the initial phase of endothelial cell transition; activin betaB was detected at later stages, and inhibin alpha was not detectable in the heart. An in vitro assay that has been used to study mesenchymal cell formation in chick was modified for use with mammalian embryos. Conditioned media from embryonic mouse cardiocyte cultures was shown to substitute for the endogenous inductive signal in these assays. The presence of activin betaA was demonstrated by Western blot analysis of the cardiocyte conditioned media (CCM). Modified antisense oligonucleotides to activin betaA inhibited the endothelial-mesenchymal transition in the assay system, which was not affected by control oligonucleotides. Adapting the avian culture system for use with mice enabled the use of tissue from mice with a null allele for activin betaA. CCM produced from embryos homozygous for the mutant betaA allele did not contain activin betaA and was used in in vitro assays. CCM lacking activin betaA produced fewer mesenchymal cells from cardiac endothelial monolayers than CCM with activin betaA. Localized expression of activin betaA in the embryonic heart indicates a possible role in the endothelial-mesenchymal transition. Bioassays in which activin betaA expression is blocked or activin betaA is absent from the media indicate that activin betaA promotes the formation of mesenchymal cells in the endothelial cushions, which are required for normal septation.
Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
C S
CS
Moore
C H
CH
Mjaatvedt
J D
JD
Gearhart
D000483:Alleles; D000818:Animals; D001681:Biological Assay; D015153:Blotting, Western; D001947:Breeding; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000737:chemistry; D004699:Endocardium / Q000166:cytology / Q000196:embryology / Q000254:growth & development / Q000378:metabolism / Q000502:physiology; D004727:Endothelium / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D005260:Female; D006321:Heart / Q000196:embryology / Q000254:growth & development / Q000502:physiology; D028322:Inhibin-beta Subunits; D007265:Inhibins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D008648:Mesoderm / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D051379:Mice; D008813:Mice, Inbred ICR; D008969:Molecular Sequence Data; D009206:Myocardium / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D011247:Pregnancy; D012333:RNA, Messenger / Q000096:biosynthesis
D017077:Culture Media, Conditioned; D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; C103008:inhibin beta A subunit; D007265:Inhibins; D028322:Inhibin-beta Subunits